Status:
COMPLETED
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This trial is to compare the efficacy, safety and tolerability of Rosuvastatin with Atorvastatin by assessing the change of LDL-C in patients with hypercholesterolemia and history of coronary heart di...
Eligibility Criteria
Inclusion
- Treated for or diagnosed hypercholesterolemia or have had a high risk with hypercholesterolemia
- LDL-C between 3.36mmol/L and 6.5 mmol/L if not treated with statin or between 2.6mmol/L and 4.14 mmol/L
- Fasting triglyceride less than 4.52mmol/L
Exclusion
- History of statin induced myopathy
- Unstable or uncontrolled cardiovascular diseases
- Familial dysbetalipoproteinemia
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
934 Patients enrolled
Trial Details
Trial ID
NCT00683618
Start Date
May 1 2008
End Date
July 1 2009
Last Update
March 21 2012
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Wuhan, Hubei, China
2
Research Site
Changsha, Hunan, China
3
Research Site
Shenyang, Liaoning, China
4
Research Site
Beijing, China